ABOUT US

ABOUT THE HIV CLINICAL GUIDELINES PROGRAM

Introduction: The HIV Clinical Guidelines Program is a collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. 

History: When the HIV Clinical Guidelines Program was established in 1986, the complexity of HIV care and prevention and the need to integrate rapid changes into clinical practice necessitated a coordinated response to meet the practice and informational needs of clinicians, support service providers, and consumers. The HIV Clinical Guidelines Program met those needs by drawing on the experience of clinical experts familiar with providing medical care to New York State’s HIV-infected population. Since then, the program has successfully collaborated with a broad array of stakeholders and experts to develop HIV care and prevention guidelines that are current, clear, and accessible.

Over the course of its thirty-year history, the program has successfully addressed the broad spectrum of HIV care throughout the State, and with the expanded mission of the AI, now also addresses topics in HCV care, STI care, drug user health, and LGBT health.

Mission: The mission of the Clinical Guidelines program is to develop, disseminate, and guide the implementation of state-of the-art clinical practice guidelines to improve the quality of care provided to persons living with HIV, HCV, STIs, and related comorbidities in New York State.

Expert committees: Guideline committees are composed of clinical representatives from throughout NYS, who work in a variety of practice settings, to ensure that recommendations reflect broad experience and address the needs of patients in all areas of the state. 

The AIDS Institute Guidelines Model

The diagram below outlines the continuous process of the Clinical Guidelines Program. The process ensures the relevance, adaptability, and usefulness of the clinical guidelines to practitioners and contributes to the provision of clinically current, scientifically sound treatment for patients.

⇒ Development: Experts representing multiple specialties collaborate to draft scientifically sound, clinically current guidelines for the care of adults and adolescents living with HIV infection.

⇒ Dissemination: Guidelines are disseminated through multiple channels to key target audiences using the resources of numerous AIDS Institute programs.

⇒ Implementation: Comprehensive implementation strategies promote broad adoption and integration of guideline recommendations into the daily practice of HIV care providers throughout New York State.

⇒ Evaluation: Evaluation activities increase understanding of guideline adoption and identify areas for improvement to ensure delivery of high-quality HIV care.

After clinical practice guidelines are developed, the HIV Clinical Guidelines Program actively disseminates those guidelines through a coordinated plan to reach all key audiences through email, website dissemination, the Clinical Education Initiative, social media, and other AIDS Institute resources. Expanded dissemination also involves production and distribution of clinical aids and point-of-care materials, as well as consumer material.

The Clinical Guidelines Program and the AIDS Institute Quality of Care Program work together to promote implementation of guidelines in New York State. The AIDS Institute routinely communicates information regarding best practices and practical solutions so that this information can be widely adopted by service providers. Program standards that govern service delivery in specific types of healthcare facilities encourage adoption of guideline recommendations. To enhance consumer understanding of the guidelines, the AIDS Institute develops and provides materials in multiple formats, sponsors consumer educational programs, and invites consumers who serve on the Consumer Advisory Committee to review all guidelines.

Johns Hopkins Clinical Guidelines Program: The Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases, has collaborated with the New York State Department of Health AIDS Institute since 1999 to develop and disseminate the AIDS Institute’s HIV clinical guidelines and related quality-of-care information. This website is managed by the JHU program.

Funding: The Clinical Guidelines Program is supported by New York State funds allocated through a grant to the JHU School of Medicine to support all activities of the program.

 

 

Program Leadership and Staff

New York State Department of Health AIDS Institute

The Office of the Medical Director directs the program.

  • Bruce D. Agins, MD, MPH, Medical Director
  • Lyn Stevens, MS, NP, ACRN, Deputy Director
  • Charles J. Gonzalez, MD, Associate Medical Director for Science and Policy
  • Laura Duggan Russell, MPH, Program Coordinator

The AIDS Institute OMD consists of public health professionals dedicated to enhancing the quality of life for persons with HIV by improving prevention and health care services through performance measurement and science-based initiatives. The Office of the Medical Director oversees numerous programs and initiatives including:

Johns Hopkins University School of Medicine Clinical Guidelines Program

The Johns Hopkins University School of Medicine, Division of Infectious Diseases, has collaborated with the NYSDOH AIDS Institute since 1999 to develop and disseminate HIV clinical guidelines and related quality-of-care information.

Principal Investigator Christopher J. Hoffmann, MD, MPH provides leadership and strategic to the program and lends extensive experience in both HIV clinical care and guidelines development, as well as a resolute commitment to training for HIV care providers.

The JHU team manages all aspects of guidelines development and dissemination and program administration through the efforts of the following program staff:

  • Mary Beth Hansen, MA, Project Director
  • Christina Norwood, MS, ELS, Senior Editor
  • Jennifer R Ham, MPH, Medical Editor
  • Johanna L Gribble, MA, Medical Editor
  • Jesse M Ciekot, Program Coordinator

Contact Information

JHU: This website is managed and maintained by the staff of the JHU HIV Clinical Guidelines Program. If you have questions about the website or about the JHU HIV Clinical Guidelines program, please send an email to: webmaster@hivguidelines.org.

Mailing address: JHU HIV Clinical Guidelines Program, 2700 Lighthouse Point East, Suite 260, Baltimore, MD, 21224

NYSDOH AIDS Institute: If you have questions about the NYSDOH AIDS Institute HIV Clinical Guidelines Program, please contact the Guidelines Program Coordinator, Laura Russell: laura.russell@health.ny.gov.

Mailing address: New York State Department of Health AIDS Institute, Office of the Medical Director, 90 Church Street, 13th Floor, New York, New York 10007-2919

Feedback: If you would like to submit feedback on the website and/or its content, please complete our brief survey.

Guideline Development and Committees

Expert Committees

Composition: The Clinical Guidelines Program works directly with committees composed of experts in the field who represent multiple disciplines (medicine, nursing, psychology, pharmacy, public health, social work, mental health), clinical specialties (infectious diseases, family medicine, obstetrics and gynecology, hepatology, pediatrics, psychiatry, dentistry, prevention, etc.), and various geographic regions of New York State.

A Clinical Guidelines Program Steering Committee provides oversight and strategy to the following Clinical Guidelines Program committees, each of which is responsible for developing and updating clinical practice guidelines that fall under its area of expertise. Current committees (November 2016) include the following:

Financial disclosure and confidentiality agreement: All potential and active committee members are required to sign a confidentiality agreement and to disclose annually all financial relationships with commercial entities or gifts that may be actual, potential, or perceived as conflicts of interest. Committee members must report financial relationships with commercial entities that have existed in the 12 months prior to or are expected to exist in the 12 months after the date on which they sign their disclosure form.

Guideline development process: When the Clinical Guidelines Program identifies the need to develop or update a guideline, the committee under whose purview the guideline falls convenes to determine the goals of the guideline and its content, review the published literature, and weigh new evidence for recommendations. Text is then drafted by an author who has experience with the topic of the guideline.  The guideline draft is edited by the team at JHU, and then reviewed and modified by the committee. This rigorous development process may entail multiple rounds of review, revision, rating and editing. Decision making occurs by consensus, and all guideline recommendations are reviewed by and receive the consensus approval of the full guideline committee. 

Evidence-based Recommendations: All recommendations are rated to reflect the strength of each recommendation and the quality of the supporting evidence. Ratings are reached through review of the evidence and consensus decision. If the published evidence in support of a particular recommendation is not sufficient, the group relies on collective best practices experience to develop a final statement. The rating scheme for recommendations appears below.

Recommendation Rating Scheme: 

  • Strength of recommendation: A (Strong), B (Moderate), C (Optional)
  • Quality of evidence: I (One or more randomized trials with clinical outcomes and/or validated laboratory endpoints), II (One or more well-designed, nonrandomized trials or observational cohort studies with long-term clinical outcomes), III (Expert opinion)

External review: All guidelines are reviewed by external experts in the field and by the AIDS Institute’s Consumer Advisory Committee. 

Final approval: The guideline is submitted to the AIDS Institute for review and final approval prior to publication. The AI may request additional review by other agencies and organizations when applicable.

Guideline Updates: Members of guideline committees monitor developments ongoing to maintain guideline currency, at regular intervals. Newly published data that provides support for existing recommendations will be cited in the text and the studies will be added to the reference list. If newly published data prompts a revision to recommendations or rationale, a planning committee proposes appropriate edits and determines whether any changes warrant full committee review and approval. 

Guideline Development and Committees: Medical Care Criteria Committee (Adult HIV and related guidelines)

2015-2016

Leadership

  • Chair: Samuel T. Merrick, MD, New York-Presbyterian Hospital, New York, NY
  • Vice-Chair: Joseph P. McGowan, MD, FACP, FIDSA, North Shore University Hospital, Manhasset, NY
  • Chair Emeritus: Judith A. Aberg, MD, FIDSA, FACP, Icahn School of Medicine at Mount Sinai, New York, NY
  • Medical Director: Bruce D. Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • James C.M. Brust, MD, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
  • Elliot DeHaan, MD, SUNY Downstate Medical Center, Brooklyn, NY
  • Steven M. Fine, MD, PhD, University of Rochester Medical Center, Rochester, NY
  • Jack Fuhrer, MD, Stony Brook University Medical Center, East Setauket, NY
  • Christine A. Kerr, MD, Hudson River HealthCare, Beacon, NY
  • Luz Amarilis Lugo, MD, Mount Sinai Comprehensive Health Program-Downtown, New York, NY
  • Cynthia H. Miller, MD, Albany Medical College, Albany, NY
  • Gene Morse, PharmD, FCCP, BCPS, University at Buffalo, Buffalo, NY
  • David C. Perlman, MD, Mount Sinai Beth Israel, New York, NY
  • Noga Shalev, MD, Columbia University Medical Center, New York, New York
  • Rona M. Vail, MD, Callen-Lorde Community Health Center, New York, NY

Agency, Consumer, and Program Liaisons

  • Medical Society of the State of New York: William M. Valenti, MD, FIDSA, Trillium Health, Rochester, NY
  • New York City Department of Health and Mental Hygiene: Julie E. Myers, MD, MPH, NYC DOHMH, Long Island City, NY
  • New York City Health + Hospitals Liaison: Carlos Salama, MD, Elmhurst Hospital Center, Elmhurst, NY
  • New York State Department of Corrections and Community Supervision: Carl J. Koenigsmann, MD, NYS DOCCS, Albany, New York
  • New York State Department of Health AIDS Institute: Charles J. Gonzalez, MD, New York, NY
  • New York State Department of Health AIDS Institute, Clinical Education Initiative: Cheryl A. Smith, MD, AIDS Institute; Antonio E. Urbina, MD, Mount Sinai St Luke’s, New York, NY
  • New York State Department of Health AIDS Institute HIV Quality of Care Advisory Committee: Peter G. Gordon, MD, Columbia University College of Physicians and Surgeons, New York, NY
  • New York State Department of Health Office of Health Insurance Programs: Douglas G. Fish, MD, NYSDOH, Albany, NY
  • New York State Department of Veterans Affairs Medical Center: Sheldon T Brown, MD, James J. Peters Veterans Affairs Medical Center, Bronx, NY
  • Treatment Action Group: Mark Harrington and Jeremiah Johnson, TAG, New York, NY
  • Women’s Health: Gina M. Brown, MD, Bethesda, MD

EXTERNAL CONTRIBUTORS AND REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in adult HIV care. 

Gastrointestinal Complications: Douglas T. Dieterich, MD, Mount Sinai School of Medicine, New York, NY (Peer Reviewer); Michael Poles, MD, New York University Medical Center, New York, NY (Peer Reviewer)

HAV/HIV Co-Infection: Elizabeth Rausch-Phung, MD, MPH, New York State Department of Health, Albany, NY (Peer Reviewer); Daniel Kuhles, MD, New York State Department of Health, Albany, NY (Peer Reviewer)

HIV-2: Grace Y. Minamoto, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Elizabeth R. Jenny-Avital, MD, Jacobi Medical Center, Bronx, NY (Contributor); Lucia V. Torian, PhD, New York City Department of Health and Mental Hygiene, Long Island City, NY (Contributor); Phyllis Kanki, PhD, Harvard School of Public Health, Boston, MA (Peer Reviewer); Monica M. Parker, PhD, Wadsworth Center, NYSDOH, Albany, NY (Peer Reviewer)

HIV Testing (2016): Monica M. Parker, PhD, New York State Department of Health Wadsworth Center, Albany, NY (Peer Reviewer)

Kidney Disease in HIV-Infected Patients: Jonathan A. Winston, MD, Mount Sinai School of Medicine, New York (Contributor); Andy Choi, MD, University of California, San Francisco, CA (Peer Reviewer); Christina M. Wyatt, MD, Mount Sinai School of Medicine, New York (Peer Reviewer)

Menstrual Disorders in HIV-Infected Women: David C Foster, MD, MPH, University of Rochester School of Medicine and Dentistry, Rochester, NY (Contributor);  John F.J. Clark, MD, Columbia University Medical Center, New York, NY (Peer Reviewer)

Neurologic Complications: David Simpson, MD, Mount Sinai Medical Center, New York, NY (Contributor); Lydia B. Estanislao, MD, Mount Sinai Medical Center, New York, NY (Contributor); Anthony Geraci, MD, Mount Sinai Medical Center, New York, NY (Contributor); David B. Clifford, MD, Washington University School of Medicine, St. Louis, MO (Peer Reviewer) ; Karl Kieburtz, MD, MPH, University of Rochester Medical Center, Rochester, NY (Peer Reviewer) 

Oral Health Complications: Stuart Fischman, DMD, SUNY at Buffalo, Buffalo, NY (Contributor); Georgina Zabos, DDS, MPH, Columbia University School of Dental and Oral Surgery, New York, NY (Peer Reviewer) 

PEP Following Non-Occupational Exposure: Daniel J Egan, MD, FACEP, St Luke’s Roosevelt Hospital Center, New York, NY (Peer Reviewer)

PEP Following Occupational Exposure: Yvette Calderon, MD, MS, Jacobi Medical Center, Bronx, NY (Peer Reviewer); Michela T Catalano, MD, Albert Einstein College of Medicine, Bronx, NY (Peer Reviewer); Daniel J Egan, MD, FACEP, St Luke’s Roosevelt Hospital Center, New York, NY (Peer Reviewer)

PEP for Victims of Sexual Assault: Elizabeth Louise Berberian, MPH, New York State Department of Health AIDS Institute, Albany, NY (Contributor); Mary Chris Schultz, BS, New York State Department of Health AIDS Institute, Albany, NY (Contributor)

Perioperative Management: Sian Jones, MD, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY (Contributor); Frances R. Wallach, MD, Mount Sinai School of Medicine, New York, NY (Contributor); Michelle S. Cespedes, MD, New York University School of Medicine, New York, NY (Peer Reviewer); Susan A Olender, MD, Columbia Presbyterian Medical Center, New York, NY (Peer Reviewer) 

Primary Care Approach to the Patient with HIV Infection: Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Kinga Cieloszyk, MD, MPH, New York City Department of Health and Mental Hygiene, New York, NY (Contributor); William M. Valenti, MD, University of Rochester School of Medicine and Dentistry, Rochester, NY (Peer Reviewer) 

 

Guideline Development and Committees: Subcommittee on the Care of Adolescents with HIV Infection

2006-2012

Contributing Members

  • Jeffrey M Birnbaum, MD, MPH, SUNY Downstate Medical Center, Brooklyn, NY
  • Aracelis D Fernández, MD, FAAP, Children’s Hospital at Montefiore, Bronx, NY
  • Natalie M Neu, MD, MPH, Columbia University, New York, NY
  • Anthony Vavasis, MD, Callen-Lorde Community Health Center, New York, NY

AIDS Institute Staff and Liaisons

  • Associate Medical Director for Science and Policy: Charles J. Gonzalez, MD, New York, NY
  • Director, Perinatal HIV Prevention Program: Barbara L. Warren, BSN, MPH, PNP, Albany, NY

EXTERNAL GUIDELINE CONTRIBUTORS AND REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in adolescent HIV care. 

Ambulatory Care of HIV-Infected Adolescents: Geoffrey A Weinberg, MD, University of Rochester School of Medicine and Dentistry, Rochester, NY (Contributor); Patricia M. Flynn, MD, St Jude Children’s Research Hospital, Memphis, TN (Peer Reviewer); Neal D. Hoffman, MD, Montefiore Medical Center, Bronx, NY (Peer Reviewer)

Care of the HIV-Infected Female Adolescent: Aracelis Fernández, MD, Albany Medical Center, Albany, NY (Peer Reviewer); Linda Levin Carmine, MD, Mount Sinai School of Medicine, New York, NY (Peer Reviewer)

Disclosure of HIV to Perinatally Infected Children and Adolescents: Alice S Myerson, CPNP, ANP, MSN, Montefiore Medical Center, Bronx, NY (Contributor); Yiu Kee Warren Ng, MD, New York Presbyterian Hospital, Columbia University Medical Center, NY (Contributor); Lori Wiener, PhD, National Cancer Institute, Bethesda, MD (Peer Reviewer); Nancy Peterson, PhD, SUNY Downstate Medical Center, Brooklyn, NY (Peer Reviewer)

HIV Disclosure to Parents and Consent to Treatment: John B. Steever, MD, Mount Sinai Adolescent Health Center, New York, NY (Peer Reviewer); Donna Futterman, MD, Children’s Hospital at Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY (Peer Reviewer)

Substance Use and Dependence Among HIV-Infected Adolescents and Young Adults: Katherine Marx, NP, SUNY Downstate Medical Center, Brooklyn, NY (Contributor); Jeffrey M. Birnbaum, MD, SUNY Downstate Medical Center, Brooklyn, NY (Contributor); Brenda Chabon, PhD, Montefiore Medical Center, Bronx, NY (Contributor); Steven J. Lee, MD, Columbia University, New York, NY (Contributor); David L. Bell, MD, Columbia University, New York, NY (Peer Reviewer); Randolph D. Muck, MEd, Center for Substance Abuse Treatment, Rockville, MD (Peer Reviewer)

Transitioning HIV-Infected Adolescents into Adult Care: under the purview of the HIV Transitional Care Working Group (no longer active).

 

Guideline Development and Committees: Hepatitis C Virus Infection Guidelines Committee

2013-to date

Leadership

  • Co-Chair: Joshua S. Aron, MD, Elmhurst Hospital Center, Elmhurst, NY
  • Co-Chair: Christine A. Kerr, MD, Hudson River Healthcare, Beacon, NY
  • Medical Director: Bruce D. Agins MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Mary Angerame, MS APN-BC, Jordan Health, Rochester, NY
  • Ayse Aytaman, MD, AGAF, FACG, Veterans Affairs New York Harbor Healthcare System, Brooklyn, NY
  • David Bernstein, MD, FAASLD, FACG, AGAF, FACP, Hofstra-Northwell School of Medicine Manhasset, NY
  • Lorna M. Dove, MD, MPH, New York-Presbyterian Hospital, New York, NY
  • John J. Faragon, PharmD, BCPS, AAHIVP, Albany Medical Center, Albany, NY
  • Douglas G. Fish, MD, New York State Department of Health, Albany, NY
  • Alain H. Litwin, MD, MPH, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
  • Kristen Marks, MD, Weill Cornell Medical College, New York, NY
  • Anthony D. Martinez, MD, University at Buffalo, Buffalo, NY
  • Brianna Norton, DO, MPH, Montefiore Medical Group, Bronx, NY
  • Russell Perry, MD, FAAFP, Bronx Lebanon Hospital, Bronx, NY
  • Ponni V. Perumalswami, MD, Icahn School of Medicine at Mount Sinai, New York, NY
  • Jeffrey J. Weiss, PhD, MS, Mount Sinai School of Medicine, New York, NY

Agency, Consumer, and Program Liaisons

  • Consumer Liaisons: Ivan Flores*, The Wellness Center at Port Morris, Bronx, NY; Cheryl Santoro, Hudson River Health Care, Peekskill, NY
  • Medical Society of the State of New York: William M. Valenti, MD, FIDSA,  Trillium Health, Rochester, NY
  • New York City Department of Health and Mental Hygiene: Fabienne Laraque*, MD, MPH, NYC DOHMH, Long Island City, NY
  • New York City Health and Hospitals: Vinh Pham, MD, PhD, Bellevue Hospital Center, New York, NY
  • New York State Department of Corrections and Community Supervision: Paula R. Bozer, MD, Wende Correctional Facility, Alden, NY, and Carl J. Koenigsmann, MD, Albany, NY
  • New York State Department of Health AIDS Institute: Colleen Flanigan, RN, MS, Albany, NY; Charles J. Gonzalez, MD, New York, NY
  • New York State Department of Health AIDS Institute, Clinical Education Initiative: Cheryl A. Smith, MD, New York, NY
  • New York State Office of Alcoholism and Substance Abuse Services Liaison: Michele Falkowski*, RN, BSN, CARN, Orangeburg, NY
  • Treatment Action Group: Annette Gaudino, TAG, New York, NY; Tracy Swan*, TAG, New York, NY

AIDS Institute HIV Clinical Guidelines Program Committee Reviewers

  • Medical Care Criteria Committee: Samuel T. Merrick, MD (Chair), New York-Presbyterian Hospital, New York, NY; Joseph P. McGowan, MD, FACP, FIDSA (Vice-Chair), Northwell Health, Manhasset, NY; Judith A. Aberg, MD, FIDSA, FACP (Chair Emeritus), Icahn School of Medicine at Mount Sinai, New York, NY
  • Committee for the Prevention of Mother to Child Transmission of HIV: Rodney L. Wright, MD, MS (Co-Chair), Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY

EXTERNAL PEER REVIEWERS

  • Douglas T. Dieterich, MD, New York-Presbyterian Hospital, New York, NY
  • Ira M. Jacobsen, MD, Mount Sinai Beth Israel, New York, NY
  • Oluwaseun Falade-Nwulia, MBBS, MPH, Johns Hopkins University School of Medicine, Baltimore, MD
  • Karla Thorton, MD, University of New Mexico School of Medicine, Albuquerque, NM

*These individuals participated in the early development of the HCV guideline but were no longer in their positions, or were not able to serve as liaisons at the conclusion of the project.

Guideline Development and Committees: Mental Health Guideline Committee

2009 to date

Leadership

  • Chair: Milton L. Wainberg, MD, Columbia University College of Physicians and Surgeons, New York, NY
  • Chair Emeritus: Francine Cournos, MD, Northeast/Caribbean AIDS Education and Training Center, New York, NY
  • Medical Director: Bruce D. Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Kenneth B. Ashley, MD, Beth Israel Medical Center, New York, NY
  • Barbara A. Conanan, RN, MS, Lutheran Family Health Centers, Brooklyn, NY
  • Denise E. Leung, MD, NewYork-Presbyterian Hospital, New York, NY (Alternate)
  • Joseph Z. Lux, MD, Bellevue Hospital, New York, NY
  • Peter Meacher, MD, AAHIVS, FAAFP, Callen-Lorde Community Health Center, New York, NY
  • Joseph P. Merlino, MD, MPA, SUNY Downstate Medical Center, Brooklyn, NY
  • Warren Yiu Kee Ng, MD, NewYork-Presbyterian Hospital, New York, NY
  • Khakasa H. Wapenyi, MD, Mount Sinai Comprehensive Health Program-Downtown,  New York, NY
  • Rachel Wolfe, PhD, Wyckoff Heights Medical Center, Brooklyn, NY

Agency, Consumer, and Program Liaisons

  • New York City Department of Health and Mental Hygiene Liaison: Graham Harriman, MA, Long Island City, NY
  • New York State Department of Health AIDS Institute: John J. Hartigan, LCSW, Albany, NY
  • New York State Office of Mental Health: James J. Satriano, PhD, Albany, NY
  • New York Veterans Affairs Hospital: Mark V. Bradley, MD, New York Veterans Affairs Hospital, New York, NY

EXTERNAL CONTRIBUTORS AND REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in mental health and HIV care. 

Adherence to ART among HIV-Infected Patients with Mental Health Disorders: David Bangsberg, MD, MPH, University of California, San Francisco, CA (Peer Reviewer); Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Peer Reviewer)

Anxiety Disorders in Patients with HIV: John M. Budin, MD, Columbia University College of Physicians and Surgeons, New York, NY (Contributor)

Cogntive Disorders in Patients with HIV: Giovanni Schifitto, MD, University of Rochester School of Medicine, Rochester, NY (Contributor); John A.R. Grimaldi, Jr, MD, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY (Contributor); Paul Pham, PharmD, The Johns Hopkins University, Baltimore, MD (Contributor)

Depression and Mania in Patients with HIV: L. Jeannine Bookhardt-Murray, MD, Harlem United Community AIDS Center, New York, NY (Contributor); Gina M. Brown, MD, New York City Department of Health and Mental Hygiene, New York, NY (Contributor)

Insomnia Screening and Treatment: A Quick Reference Guide for HIV Primary Care Clinicians: David A. Wohl, MD, The University of North Carolina, Chapel Hill, NC (Peer Reviewer)

Personality Disorders in Patients with HIV: L. Jeannine Bookhardt-Murray, MD, Harlem United Community AIDS Center, New York, NY (Contributor); Sharon B. Mannheimer, MD, Harlem Hospital Center, New York, NY (Peer Reviewer); Glenn J. Treisman, MD, PhD, The Johns Hopkins University, Baltimore, MD (Peer Reviewer)

Severe and Persistent Mental Illness in Patients with HIV: James J. Satriano, PhD, Columbia University College of Physicians and Surgeons, New York, NY (Contributor); Glenn J Treisman, MD, PhD, The Johns Hopkins University, Baltimore, MD (Peer Reviewer); P. Karen McKinnon, MA, Columbia University, New York, NY (Peer Reviewer)

Somatic Symptoms in Patients with HIV: L. Jeannine Bookhardt-Murray, MD, Harlem United Community AIDS Center, New York, NY (Contributor); Francine Rainone, PhD, DO, MS, Montefiore Medical Center, Bronx, NY (Contributor); Todd P. Loftus, MD, New York, NY (Contributor); Khakasa H. Wapenyi, MD, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY (Peer Reviewer); Glenn J. Treisman, MD, PhD, The Johns Hopkins University, Baltimore, MD (Peer Reviewer)

Suiciality and Violence in Patients with HIV: John A.R. Grimaldi, Jr, MD, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY (Contributor)

 

 

 

 

 

 

 

Guideline Development and Committees: Perinatal Transmission Prevention Guideline Committee

2014 to date

Leadership

  • Co-Chair: Rodney L. Wright, MD, MS, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
  • Co-Chair: Murli Purswani, MBChB, FAAP, Bronx-Lebanon Hospital Center, Bronx, NY
  • Medical Director: Bruce D. Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • Consulting Women’s Health Expert: Gina M. Brown, MD, National Institutes of Health, Bethesda, MD
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Lan L. Adams, MD, MPH, Women and Children’s Hospital of Buffalo, Buffalo, NY
  • David A. Baker, MD, Stony Brook School of Medicine, Stony Brook, NY
  • Keith A. Eddleman, MD, Ichan School of Medicine at Mount Sinai, New York, NY
  • Gary S. Eglinton, MD, New York Hospital Queens, Flushing, NY
  • Marc D. Foca, MD, Children’s Hospital of New York, New York, NY
  • Mahmoud M. Hassanein, MD, Brookdale University Hospital, Brooklyn, NY
  • Angela D. Kerr, MD, Brooklyn Hospital Center, Brooklyn, NY
  • Howard L. Minkoff, MD, FACOG, Maimonides Medical Center, Brooklyn, NY
  • David Rosenthal, DO, PhD, North Shore-LIJ Medical Group, Great Neck, NY
  • Renee Samelson, MD, MPH, Albany Medical Center, Albany, NY
  • Roberto P. Santos, MD, MSCS, Albany Medical Center, Albany, NY
  • Maria Teresa Timoney, CNM, Bronx Lebanon Hospital Center, Bronx, NY
  • Geoffrey A. Weinberg, MD, FAAP, FIDSA, University of Rochester School of Medicine and Dentistry, Golisano Children’s Hospital, Rochester, NY
  • Leonard B. Weiner, MD, SUNY Upstate Medical University, Syracuse, NY
  • Andrew A. Wiznia, MD, Jacobi Medical Center, Bronx, NY

Agency, Consumer, and Program Liaisons

  • New York State Department of Health AIDS Institute: Barbara L. Warren, BSN, MPH, PNP, Albany, NY; Lisa M. Haskin, RN, BS, Albany, NY

EXTERNAL CONTRIBUTORS AND REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in pregnancy and HIV infection. 

Acute HIV Infection in Pregnancy: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor)

Care of the HIV-Exposed Infant with Indeterminate Status: Murli U Purswani, MBChB, FAAP, Bronx-Lebanon Hospital Center, Bronx, NY(Peer Reviewer); Joseph S Cervia, MD, MBA, FACP, FAAP, FIDSA, AAHIVS, Hofstra North Shore, Long Island Jewish School of Medicine, Hempstead, NY (Peer Reviewer); Roberto P Santos, MD, MSc, Albany Medical Center, Albany, NY (Peer Reviewer)

Diagnosis of Pediatric HIV Infection in HIV-Exposed Infants: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor); Roberto Posada, MD, Mount Sinai Hospital, NY (Contributor)

HIV Testing During Pregnancy and at Delivery: Monica M Parker, PhD, Laboratory of Bloodborne Diseases, Wadsworth Center, New York State Department of Health, Albany, NY (Contributor)

Preconception Care for HIV-Infected Women: Katherine D. LaGuardia, MD, MPH, FACOG, Ortho-McNeil Pharmaceutical, Inc., Raritan, NJ (Contributor); Katherine T. Chen, MD, MPH, Columbia University, New York, NY (Peer Reviewer); Roberta A. Stewart, MPH, Bureau of Special Populations, Prevention Division of the AIDS Institute, New York State Department of Health, New York, NY (Peer Reviewer)

 

Guideline Development and Committees: Sexually Transmitted Infections Guidelines Committee

2016-to date

Leadership

  • Chair: Marguerite A. Urban, MD, University of Rochester Medical Center, Rochester, NY
  • Vice-Chair: Michael H. Augenbraun, MD, FACP, FIDSA, SUNY Downstate, Brooklyn, NY  
  • Medical Director: Bruce D. Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Elizabeth Asiago-Reddy, MD, SUNY Upstate, Syracuse, NY
  • Gale R. Burstein, MD, MPH, FAAP, Erie County Department of Health, Buffalo, NY
  • Michael M. Gaisa, PhD, MD, Mount Sinai, New York, NY
  • Shelley Gilroy, MD, Albany Medical College, Albany, NY
  • Sachin Jain, MD, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
  • Marla J. Keller, MD, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
  • Anita P. LaSala, MD, Columbia University Medical Center, New York, NY
  • Robert Murayama, MD, MPH, Apicha Community Health Center, New York, NY
  • Michel Ng, NP, Mount Sinai School of Medicine, New York, NY
  • Thomas Panzella, PAC, HEAT/Downstate, Brooklyn, NY
  • Asa Radix, MD, MPH, FACP, AAHIVS, Callen-Lorde Community Health Center, New York, NY
  • Heather M. Territo, MD, University at Buffalo-SUNY, Buffalo, NY

Agency, Consumer, and Program Liaisons

  • New York City Department of Health and Mental Hygiene: Bisrat K. Abraham, MD, Long Island City, NY (alternate); Demetre C. Daskalakis, MD, MPH, Long Island City, NY; Tarek Mikati, MD, MPH, Long Island City, NY
  • NYC Health + Hospitals: Richard Greene, MD, FACP, FIDSA, New York, NY
  • New York State Department of Health AIDS Institute: Beatrice Aladin, MD, MPH, New York, NY; Alison Muse, MPH, Albany, NY
  • New York State Department of Health AIDS Institute Consumer Advisory Committee: David Martin, New York, NY

EXTERNAL CONTRIBUTORS AND REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in the care of adults with STIs and HIV infection. 

Bacterial Vaginosis: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Susan Blank, MD, MPH, and Kristen Harvey, MD, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Chancroid: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); Kristen Harvey, MD, Bureau of STD Control, NYC DOHMH, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Genital Herpes Simplex Virus (HSV): Barry S. Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Gonococcal and Chlamydial Infections: Douglas G. Fish, MD, Albany Medical College, Albany, NY (Contributor); Jessica E. Justman, MD, Columbia University, New York, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Human Papillomavirus (HPV): Gina M. Brown, MD, New York City Department of Health, New York, NY (Contributor); Susan Blank, MD, MPH, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer); F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Lymphogranuloma Venereum (LGV): F. Bruce Coles, DO, Bureau of STD Control, New York State Department of Health, Albany, NY (Peer Reviewer)

Syphilis: Barry S Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY (Contributor); Judith A Aberg, MD, New York University School of Medicine, New York, NY (Contributor); Eunmee H. Chun, MD, Bureau of STD Control, New York City Department of Health and Mental Hygiene, New York, NY (Peer Reviewer)

Trichomoniasis: Carola Marte, MD, Community Health Center, Inc, Meriden, NY (Contributor); Gina M Brown, MD, National Institutes of Health, Office of AIDS Research, Bethesda, MD (Contributor); Eunmee H. Chun, MD, MPH, Bureau of STD Prevention and Control, New York City Department of Health and Mental Hygiene, Long Island City, NY (Peer Reviewer); Demetre C Daskalakis, MD, Bellevue Hospital, NYU Langone Medical Center, New York, NY (Peer Reviewer)

Guideline Development and Committees: Substance Use Guidelines Committee

2016-to date

Leadership

  • Chair: Chinazo O. Cunningham, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY
  • Vice-Chair: Kelly S. Ramsey, MD, MPH, MA, FACP, Hudson River Health Care, Poughkeepsie, NY
  • Consulting Expert: Sharon L. Stancliff, MD, Harm Reduction Coalition Liaison, New York, NY
  • Medical Director: Bruce D. Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Marcus Bachhuber, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY
  • Michael L. Christie, MD, University of Rochester Medical Center, Rochester, NY
  • Angela G. Giovanniello, PharmD, AAHIVP, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY
  • Carl L. Hart, PhD, Columbia University College of Physicians and Surgeons, New York, NY
  • Raymond Harvey, MD, Institute for Family Health, Kingston, NY
  • Giliane Joseph, MD, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY
  • Stephen A. Maisto, PhD, Syracuse University, Syracuse, NY
  • Jennifer McNeely, MD, MS, NYU School of Medicine, New York, NY
  • Shadi Nahvi, MD, MS, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY
  • David C. Perlman, MD, Icahn School of Medicine at Mount Sinai, New York, NY
  • Stephen Ross, MD, NYU School of Medicine, New York, NY
  • Paul Updike, MD, St. Vincent’s/Sisters Hospital, Buffalo, NY
  • Roberto Zavala, MD, START Treatment & Recovery Centers, Brooklyn, NY

Agency, Consumer, and Program Liaisons

  • New York City Department of Health and Mental Hygiene: Hillary Kunins, MD, MPH, MS, Long Island City, NY
  • New York State Department of Health AIDS Institute: Allan Clear
  • New York State Department of Health AIDS Institute Consumer Advisory Committee: John Anthony Eddie, Staten Island, NY
  • New York State Department of Health, Office of Alcoholism and Substance Abuse: Charles W. Morgan, MD, DFSAM, FAAFP, DABAM, Albany, NY
  • New York State Department of Health, Office of Alcoholism and Substance Abuse: Michele Falkowski, RN, BSN, CARN, NYS OASAS Liaison, Orangeburg, NY

 EXTERNAL CONTRIBUTORS AND PEER REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in substance use and HIV care. 

Adherence to Antiretroviral Therapy Among Substance Users: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Contributor); David Bangsberg, MD, MPH, University of California, San Francisco, CA (Peer Reviewer); Lois Eldred, DrPH, Health Resources and Services Administration, HIV/AIDS Bureau, Rockville, MD (Peer Reviewer)

Aspects of Primary Care for the HIV-Infected Substance User: David C Perlman, MD, Beth Israel Medical Center, and National Development and Research Institutes, New York, and Albert Einstein College of Medicine, Bronx, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Vladimir Poznyak, MD, PhD, World Health Organization (Peer Reviewer); Jeffrey Samet, MD, MA, MPH, Boston University School of Medicine, Boston, MA (Peer Reviewer)

Care of the Hospitalized HIV-Infected Substance User: Brenda Chabon, PhD, Montefiore Medical Center, Bronx, NY (Contributor); Eunmee H. Chun, MD, New York State Department of Health AIDS Institute, New York, NY (Contributor); Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Sheree Starrett, MD, Casa Promesa, Bronx, NY (Peer Reviewer); Stanley R. Yancovitz MD, Beth Israel Medical Center, New York, NY (Peer Reviewer)

Clinical Management of Alcohol Use and Abuse in HIV-Infected Patients: Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh, PA (Contributor); Thomas Kresina, PhD, National Institute on Drug Abuse, Bethesda, MD (Peer Reviewer); Richard Saitz, MD, MPH, Boston University School of Medicine, Boston, MA (Peer Reviewer)

Drug-Drug Interactions Between ARV Agents, Medications Used in Substance Use Treatment, and Recreational Drugs: John J. Faragon, PharmD, Albany Medical Center, Albany, NY (Contributor); Paul Pham, PharmD, The Johns Hopkins University, Baltimore, MD (Contributor); Elinore F. McCance-Katz, MD, PhD, Virginia Commonwealth University, Richmond, VA (Peer Reviewer)

Medical Care of HIV-Infected Substance-Using Women: Diane M. Rudnick, MEd, New York State Department of Health AIDS Institute, New York, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Hillary Kunins, MD, MPH, Montefiore Medical Center, Bronx, NY (Peer Reviewer); Barbara C. Zeller, MD, Project Samaritan AIDS Services, Bronx, NY (Peer Reviewer)

Mental Health Disorders Among Substance-Using HIV-Infected Patients: Steven L Batki, MD, SUNY Upstate Medical University, Syracuse, NY (Contributor); John AR Grimaldi, Jr, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY (Contributor); Marshall Forstein, MD, The Cambridge Hospital, Cambridge, MA (Peer Reviewer); George E. Woody, MD, University of Pennsylvania, and the Philadelphia VA Medical Center, Philadelphia, PA (Peer Reviewer)

Pain in the HIV-Infected Substance User: Robert B. Whitney, MD, Erie County Medical Center, Buffalo, NY; William S. Breitbart, MD, Memorial Sloan-Kettering Cancer Center, New York, NY (Peer Reviewer); Andrew Rosenblum, PhD, National Development and Research Institutes, New York, NY (Peer Reviewer)

Screening and Ongoing Assessment for Substance Use; Barbara Chaffee, MD, MPH, United Health Services, Binghamton, NY (Contributor); Thomas F. Babor, PhD, MPH, The Alcohol Research Center at the University of Connecticut School of Medicine, Farmington, CT (Peer Reviewer); Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh, PA (Peer Reviewer)

Smoking Cessation in HIV-Infected Patients: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx, NY (Contributor); Alvaro Carrascal, MD, MPH, New York State Department of Health, Albany, NY (Peer Reviewer); Kimber P. Richter, PhD, MPH, University of Kansas Medical Center, Kansas City, KS (Peer Reviewer)

Substance Use Treatment Modalities for HIV-Infected Substance Users: Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Marc N. Gourevitch, MD, MPH, New York University School of Medicine, New York, NY (Contributor); Jeffrey Rothman, New York State Department of Health AIDS Institute, New York (Contributor); Deborah Brotman, MD, Center For Comprehensive Health Practice, New York, NY (Peer Reviewer)

What Are These Drugs? Steven S Kipnis, MD, FACP, FASAM, New York State Office of Alcoholism and Substance Abuse Services, Orangeburg, and Albany Medical College, Albany, NY (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor)

Working With the Active User: Nancy Murphy, NP, St Luke’s Roosevelt Hospital Center, and CUNY Graduate Center, New York, NY (Contributor); Robert B. Whitney, MD, Erie County Medical Center, Buffalo (Contributor); Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY (Contributor); Kumara Singaravelu, MBBS, MPH, New York County Health Services Review Organization, New York, NY (Peer Reviewer)

 

 

 

 

 

Guideline Development and Committees: Women with HIV Infection Guidelines Committee

Ended in 2008

Leadership

  • Chair: Mary Jo Fink, MD, Columbia University College of Physicians and Surgeons, New York, NY
  • Vice-Chair: Barbara C Zeller, MD, HELP/Project Samaritan AIDS Services, Inc, Bronx, NY
  • Medical Director: Bruce D. Agins, MD, MPH, New York State Department of Health AIDS Institute, New York, NY
  • JHU Principal Director: Christopher J. Hoffmann, MD, MPH, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Machelle Allen, MD, Bellevue Hospital Center, New York, NY
  • Kathryn Anastos, MD, Montefiore Medical Center, Bronx, NY
  • Jeffrey M. Birnbaum, MD, MPH, SUNY Downstate Medical Center, Brooklyn, NY
  • Susan E. Cohn, MD, MPH, Northwestern University Feinberg School of Medicine, Chicago, IL
  • Vanessa E. Cullins, MD, MPH, MBA, Planned Parenthood Federation of America, New York, NY
  • Katherine D. LaGuardia, MD, MPH, FACOG, Ortho-McNeil Janssen Scientific Affairs, Raritan, NJ
  • Howard Minkoff, MD, Maimonides Medical Center, Brooklyn, NY
  • Renee Samelson, MD, MPH, Albany Medical College, Albany, NY
  • Diane J. Tufaro, NP, Westchester Medical Center, Valhalla, NY
  • Janice R. Verley, MD, Nassau University Medical Center, East Meadow, NY
  • Mary Vogler, MD, Weill College of Medicine, New York, NY
  • Rodney L. Wright, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY

Agency, Consumer, and Program Liaisons

  • New York State Department of Healh AIDS Institute: Barbara L Warren, BSN, MPH, PNP, Albany, NY
  • New York State Department of Healh AIDS Institute Expert Consultant on Women’s Health: Gina M. Brown, MD, Bethesda, MD

Guideline Development and Committees: Dental Standards of Care Committee

2012 to date

Leadership

  • Chair: Stephen N. Abel, DDS, MSD, University at Buffalo-SUNY, Buffalo, NY
  • Deputy Medical Director: Lyn C. Stevens, MS, NP, ACRN, Albany, NY, New York State Department of Health AIDS Institute, Office of the Medical Director
  • JHU Principal Investigator: Christopher J. Hoffmann, MD, Johns Hopkins University School of Medicine, Baltimore, MD

Contributing Members

  • Victor M. Badner, DMD, MPH, North Bronx Healthcare Network, Bronx, NY
  • Mary Therese Biltucci, RDH, MA, University of Rochester, Rochester, NY
  • Stanley J. Boyd, DMD, Healthy Chelsea Dentistry, New York, NY
  • Gwen Cohen Brown, DDS, FAAOMP, New York City College of Technology, Brooklyn, NY
  • Dolores Cottrell-Carson, DDS, MSHA, New York State Board for Dentistry, Albany, NY
  • Maria de los Angeles Figueroa, DMD, Bronx-Lebanon Hospital Center, Bronx, NY
  • Mary J. D’Silva, DDS, NYS DOC and Community Supervision, Albany, NY
  • Robert D. Kelsch, DMD, Northwell Health, Manhasset, NY
  • Michael A. Kozlowski, DDS, Unity Dental Group, Rochester, NY
  • Kareem J. Merrick, DDS, Harlem United Community Clinic, New York, NY
  • Calix Ramos-Rodriguez, DMD, Lutheran Medical Center, Brooklyn, NY
  • Miriam R. Robbins, DDS, MS, Winthrop University Hospital, Mineola, NY
  • Dara J. Rosenberg, DDS, MS, MPH, St. Barnabas Hospital, Bronx, NY
  • Terrence T. Thines, DDS, MS, SUNY Upstate Medical University, Syracuse, NY

Agency, Consumer, and Program Liaisons

  • New York State Department of Corrections and Community Supervision: Britta Viereckl-Prast, DMD, Bedford Hills, NY
  • New York State Department of Health AIDS Institute Consumer Advisory Committee: Jahlove Serrano, Bronx, NY; David Martin, New York, NY, New York State Department of Health AIDS Institute Consumer Advisory Committee

EXTERNAL CONTRIBUTORS AND REVIEWERS

With gratitude, we acknowledge the efforts of the following external experts who made substantial contributions to or provided peer reviews of clinical guidelines addressing the following topics in oral health care for adults with HIV infection

Clinical Manifestations and Management of HIV-Related Periodontal Disease: Barbara Gerbert, PhD, University of California School of Dentistry, San Francisco, CA (Peer Reviewer)

Diagnosis and Management of Soft-Tissue Lesions: Stuart L Fischman, DMD, State University of New York, Buffalo, NY (Contributor); Michael Glick, DMD, University of Pennsylvania School of Dental Medicine, Philadelphia, PA (Peer Reviewer)

General Principles: Georgina P. Zabos, DDS, MPH, Columbia University School of Dental and Oral Surgery, New York, NY (Contributor); Amneris E. Luque, MD, Strong Memorial Hospital, Rochester, NY (Peer Reviewer); Barbara H. Chaffee, MD, MPH, Binghamton Family Care Center, United Health Services Hospital, Binghamton, NY (Peer Reviewer); Marc N. Gourevitch, MD, MPH, New York University School of Medicine, New York, NY (Peer Reviewer)

HIV Testing in the Oral Healthcare Setting: Joan A. Phelan, DDS, New York University College of Dentistry, New York, NY (Peer Reviewer); Michael Hatton, DDS, University at Buffalo, Buffalo, NY (Peer Reviewer)

Infection Control: Helene Bednarsh, RDH, MPH, HIV Dental at Boston Public Health Commission, Boston, MA (Peer Reviewer)

Oral and Maxillofacial Surgery: David Drohan, DDS, Albany Medical College, Division of Dentistry, Albany, NY (Contributor); Paul E Gates, DDS, MBA, Bronx-Lebanon Hospital Center, Bronx, NY (Contributor); Robert S Glickman, DMD, New York University College of Dentistry, New York, NY (Peer Reviewer)

 

 

Guideline Development and Committees: PrEP Advisory Committee

2012-2013

Contributing Members

  • Judith A Aberg, MD, FIDSA, FACP, ICAHN School of Medicine at Mount Sinai,  New York, NY
  • Oladipo A. Alao, MD, MPH, MetroPlus Health Plan, New York, NY
  • John G. Bartlett, MD, Johns Hopkins University School of Medicine,  Baltimore, MD
  • James F. Braun, DO, Physicians’ Research Network (PRN),  New York, NY
  • John M. Conry, PharmD, BCPS, AAHIVP, Saint John’s University, Queens, NY
  • Silvia C. Cunto-Amesty, MD, MPH, Columbia University, New York, NY
  • Jerome Ernst, MD, Amida Care, New York, NY
  • Kevin Fiscella, MD, MPH, University of Rochester School of Medicine and Dentistry, Rochester, NY
  • Paul Galatowitsch, PhD, New York, NY
  • Raymond K. Ganoe, MSW, Evergreen Association of WNY, Inc, Buffalo, NY
  • Peter G. Gordon, MD, Columbia University College of Physicians and Surgeons, New York, NY
  • John A. Guidry, PhD, Community Health and Research, New York, NY
  • Terry Hamilton, New York City Health and Hospitals Corporation, New York, NY
  • Barbara E. Johnston, MD, Mount Sinai Comprehensive Health Program-Downtown, New York, NY
  • Jessica E. Justman, MD, Mailman School of Public Health, Columbia University, New York, NY
  • Byron Kennedy, MD, PhD, MPH, Monroe County Health Department, Rochester, NY
  • Michelle Lopez, Brooklyn Multispeciality Group, Brooklyn, NY
  • Samuel T. Merrick, MD, NewYork-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY
  • Luis Freddy Molano, MD, Community Healthcare Network, New York, NY
  • Robert Murayama, MD, MPH, Asian and Pacific Islander Coalition on HIV/AIDS, Inc (APICHA), New York, NY
  • Julie E. Myers, MD, MPH, New York City Department of Health and Mental Hygiene, Queens, NY
  • John A. Nelson, PhD, CPNP, AIDS Education and Training Center National Resource Center, Newark, NJ
  • David S. Rubin, MD, New York Hospital Queens, Flushing, NY
  • Heriberto Sanchez Soto, Hispanic AIDS Forum, New York, NY
  • Benjamin Tsoi, MD, MPH, New York City Department of Health and Mental Hygiene, Queens, NY
  • Antonio E Urbina, MD, St Luke’s and Roosevelt Hospitals, New York, NY
  • Rona M. Vail, MD, Callen-Lorde Community Health Center, New York, NY
  • William Valenti, MD, FIDSA, The Medical Society of the State of New York, Albany, NY
  • Rodney L. Wright, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
  • Barry S. Zingman, MD, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
  • Ashley Zuppelli, PharmD, AAHIVP, Trillium Health, Rochester, NY

New York State Department of Health AIDS Institute Liaisons

  • Jeffrey M Birnbaum, MD, MPH, SUNY Downstate Medical Center, Brooklyn, NY
  • L. Jeannine Bookhardt-Murray, MD, Harlem United Community AIDS Center, New York, NY
  • Gina M. Brown, MD, National Institutes of Health, Bethesda, MD
  • Demetre C. Daskalakis, MD, Mount Sinai Comprehensive Health Program-Downtown, New York, NY
  • Sharon L Stancliff, MD, Harm Reduction Coalition, New York, NY

About this Website

Purpose

The HIV Clinical Resource website publishes the clinical practice guidelines and related materials produced by the Clinical Guidelines Program. The program is a collaborative effort of the New York State Department of Health AIDS Institute’s Office of the Medical Director (OMD) and the Johns Hopkins University School of Medicine, Division of Infectious Diseases. This website is maintained and managed by the JHU Clinical Guidelines program, within the Johns Hopkins University School of Medicine, Division of Infectious Diseases. 

Production and Development 

  • WordPress development and programming: Alexei Yukna
  • Graphic design: Laura Hatcher, Hatcher Design Office
  • Managing Editor: Mary Beth Hansen
  • Website production: Jesse Ciekot and Hanna Gribble

Editorial Policies & Procedures

This website is produced and maintained by the JHU Clinical Guidelines Program in the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases. The site does not does not purport to advance any official positions of JHU, the JHU School of Medicine, or the Division of Infectious Diseases. The JHU Clinical Guidelines Program, in collaboration with the New York State Department of Health (NYSDOH) AIDS Institute (AI) maintains editorial control of all materials published on this site, and unless noted otherwise, all materials posted on this site have been produced under the auspices NYSDOH AIDS Institute Clinical Guidelines Program.

Mention of specific products by generic or brand name does not constitute endorsement by the Clinical Guidelines Program, or its committee members, editors, or staff; NYSDOH or the AI or its staff. Any mention of specific products is for the informational purposes only. Regarding specific products or drugs, physicians and other health care providers are advised to consult their normal resources before prescribing to their patients.

The JHU Clinical Guidelines Program does not provide clinical care and does not provide clinical or medical advice. 

Contact Us 

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Privacy

This website is designed to provide public access to the clinical practice guidelines published by the JHU Clinical Guidelines Program on behalf of and under the direction of the New York State Department of Health AIDS Institute Clinical Guidelines Program.

The JHU Clinical Guidelines Program recognizes the importance of protecting the privacy of visitors to the HIV Clinical resource website and of subscribers to the site mailing list and to the monthly Topic, Trends, and Updates e-mail update.

Stored information: Most information transmitted over the Internet is not secure; thus, confidentiality cannot be guaranteed. However, of the information transmitted via your visit to the HIV Clinical Resource website, we store the following: the IP address from which you access the Internet, the date and time, the Internet address of the Web site from which you linked directly to our site, the name of the file or the words you searched, and the browser used to access our site. This information is used to measure the number of visitors to the various sections of our site and identify system performance or problem areas. We also use this information to help us improve features of the site and to make the site more useful.

Personally provided information: If you choose to provide us with personal information by sending an email, or by subscribing to one or both of our mailing lists and submitting that information it through our Web site, we will use that information to respond to your message, to send you email that you have asked to receive, and to help us provide you with information or material that you may request. We do not give, share, sell, or transfer any of your personal information to a third party unless required by law.

If you submit a question that would be best answered by a staff member of the NYSDOH AIDS Institute, we may forward your question to that staff member. When we do, we may or may not include your email address so the staff member may respond to you directly. Submitting a question through this website constitutes your tacit agreement with the actions the JHU website managers may take to secure the best answer possible in a timely manner.

Links to other sites: For the convenience of those who access and use the content published on this site (ie, the site users), many pages contain links to Web pages and Web sites that are not managed by the JHU Clinical Guidelines program. Neither the JHU Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute Clinical Guidelines Program control or take responsibility for the content of those Web sites. Links from this Web site to Web sites not managed by any of the entities named above do not imply endorsement or credibility of the service, information, or product offered through the linked sites. Links are provided to make it easy for users to access supplementary content. 

Some of the pages on this site provide links to other Web sites that provide health information. Once a user links to another site, she or he is subject to the privacy policy of that other site.

Disclaimer: The information provided in this privacy statement should not be construed as giving business, legal, or other advice, or warranting as fail proof, the security of information provided through this website.

Terms of Use

While every possible effort if made to post accurate and reliable information on this website, neither the JHU HIV Clinical Guidelines Program, neither the JHU HIV Clinical Guidelines Program, nor The Johns Hopkins University nor The Johns Hopkins School of Medicine, nor the NYSDOH AIDS Institute HIV Clinical Guidelines Program assumes responsibility for the use or application of information posted on any page of this website or guarantees or warrants that the information posted on any page of this site is complete and without any error or inaccuracy. The website, its editors, advisors, staff, authors, and sponsoring institutions assume no responsibility for any error, omissions, or other discrepancies between the electronic documents published on this site and source materials.

Physicians and other healthcare professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience.

Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition or treatment and are encouraged to call or see their physician or other health care provider promptly with any health-related questions or concerns they may have.

This website links to websites maintained by other entities. Reasonable precautions are taken to link only to websites that publish appropriate and accurate material and are maintained by reputable organizations. However, those web pages are not under the direction or control of this website, and this website can therefore not be held responsible for the information or opinions expressed in those linked sites.

Copyright and Permissions

The use, reproduction, and distribution of original documents and related graphics from this web site is encouraged provided that full credit of source accompanies all uses, in all forms. Please note that if we have adapted or reproduced copyrighted material from another source, with permission, we cannot extend permission to reproduce. Links to pages on this site are also encouraged and may be created without seeking permission.

Any use of materials from this site should be accompanied by the following citation of source: 

This material was accessed on [dd/mo/year] on the HIV Clinical Resource website (www.hivguidelines.org). The HIV Clinical Guidelines Program is a collaborative effort of the New York State Department of Health AIDS Institute and the Johns Hopkins University Division of Infectious Diseases. Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2016. 

Requests to adapt material, i.e., to change or alter in any way material from this site for the purpose of inclusion in another publication, should be sent to editor@hivguidelines.org. Please include detailed information about the intended use and desired adaptations.

The names of the New York State Department of Health, the Johns Hopkins University Division of Infectious Diseases, HIV Clinical Resource, or its staff may not be used in publicity or advertising without express written permission. Exceptions to this include listings on web indexes, search engines, and related systems.

Contact Us

Mailing address:

JHU HIV Clinical Guidelines Program
2700 Lighthouse Point East, Suite 260
Baltimore, MD, 21224

E-mail addresses:

We will make every effort to answer e-mail submitted to any of the above addresses within 48 hours.

Mailing List

Stay Up-to-Date: Join Our Mailing List

Subscribe to Topics, Trends & Updates to receive to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use.

Visit the Topics, Trends & Updates archive to see previous issues.

Privacy: We do not sell, rent, or share our email lists with anyone. Review our Privacy Statement.

Mailing List: Privacy Statement

May 2010

Introduction

Thank you for visiting the HIV Clinical Resource website. This website is designed to make it easier and more efficient for individuals and businesses to interact with the New York State Department of Health AIDS Institute. The New York State Department of Health AIDS Institute recognizes that it is critical for individuals and businesses to be confident that their privacy is protected when they visit the New York State Department of Health AIDS Institute’s website.

Consistent with the provisions of the Internet Security and Privacy Act, the Freedom of Information Law, and the Personal Privacy Protection Law, this policy describes the New York State Department of Health AIDS Institute’s privacy practices regarding information collected from users of this website. This policy describes what information is collected and how that information is used.

For purposes of this policy, “personal information” means any information concerning a person which, because of name, number, symbol, mark, or other identifier, can be used to identify that person. The New York State Department of Health AIDS Institute does not collect any personal information about you unless you provide that information voluntarily by sending an e-mail, responding to a survey, or completing an online transaction.

Information Collected Automatically When You Visit This Website

When visiting this website the New York State Department of Health AIDS Institute automatically collects and stores the following information about your visit:

  1. User client hostname. The hostname or Internet Protocol address of the user requesting access to a state agency website
  2. HTTP header, “user agent.” The user agent information includes the type of browser, its version, and the operating system on which that the browser is running.
  3. HTTP header, “referrer.” The referrer specifies the web page from which the user accessed the current web page.
  4. System date. The date and time of the user’s request.
  5. Full request. The exact request the user made.
  6. Status. The status code the server returned to the user.
  7. Content length. The content length, in bytes, of any document sent to the user.
  8. Method. The request method used.
  9. Universal Resource Identifier (URI). The location of a resource on the server.
  10. Query string of the URI. Anything after the question mark in a URI.
  11. Protocol. The transport protocol and the version used.

None of the foregoing information is deemed to constitute personal information.

The information that is collected automatically is used to improve this website’s content and to help the New York State Department of Health AIDS Institute understand how users are interacting with the website. This information is collected for statistical analysis, to determine what information is of most and least interest to our users, and to improve the utility of the material available on the website. The information is not collected for commercial marketing purposes and the New York State Department of Health AIDS Institute is not authorized to sell or otherwise disclose the information collected from the website for commercial marketing purposes.

Cookies

Cookies are simple text files stored on your web browser to provide a means of distinguishing among users of this website. The use of cookies is a standard practice among Internet websites. To better serve you, we occasionally use “session cookies” to enhance or customize your visit to this website. Session cookies can be created automatically on the device you use to access this state agency website. They do not contain personal information and do not compromise your privacy or security. We may use the cookie feature to store a randomly generated identifying tag on the device you use to access this website. A session cookie is erased during operation of your browser or when your browser is closed.

If you wish, you may complete a registration to personalize this website and permit a “persistent cookie” to be stored on your computer’s hard drive. This persistent cookie will allow the website to recognize you when you visit again and tailor the information presented to you based on your needs and interests. The New York State Department of Health AIDS Institute uses persistent cookies only with your permission.

The software and hardware you use to access the website allows you to refuse new cookies or delete existing cookies. Refusing or deleting these cookies may limit your ability to take advantage of some features of this website.

Information Collected When You Email This Website or Complete a Transaction

During your visit to this website you may send an e-mail to the New York State Department of Health AIDS Institute. Your e-mail address and the contents of your message will be collected. The information collected is not limited to text characters and may include audio, video, and graphic information formats included in the message. Your e-mail address and the information included in your message will be used to respond to you, to address issues you identify, to improve this website, or to forward your message to another State agency for appropriate action. Your e-mail address is not collected for commercial purposes and the New York State Department of Health AIDS Institute is not authorized to sell or otherwise disclose your e-mail address for commercial purposes.

During your visit to this website, you may complete a transaction such as a survey, registration, or order form. The information, including personal information, volunteered by you in completing the transaction is used by the New York State Department of Health AIDS Institute to operate New York State Department of Health AIDS Institute programs, which include the provision of goods, services, and information. The information collected by the New York State Department of Health AIDS Institute may be disclosed by the New York State Department of Health AIDS Institute for those purposes that may be reasonably ascertained from the nature and terms of the transaction in which the information was submitted.

The New York State Department of Health AIDS Institute does not knowingly collect personal information from children or create profiles of children through this website. Users are cautioned, however, that the collection of personal information submitted in an e-mail will be treated as though it was submitted by an adult, and may, unless exempted from access by federal or State law, be subject to public access. The Agency strongly encourages parents and teachers to be involved in children’s Internet activities and to provide guidance whenever children are asked to provide personal information online.

Information and Choice

As noted above, the New York State Department of Health AIDS Institute does not collect any personal information about you unless you provide that information voluntarily by sending an e-mail, responding to a survey, or completing an online form. You may choose not to send us an e-mail, respond to a survey, or complete an online form. While your choice not to participate in these activities may limit your ability to receive specific services or products through this website, it will not normally have an impact on your ability to take advantage of other features of the website, including browsing or downloading information.

Disclosure of Information Collected Through This Website

The collection of information through this website and the disclosure of that information are subject to the provisions of the Internet Security and Privacy Act. Except as provided below or as otherwise authorized by law, the New York State Department of Health AIDS Institute will only collect personal information through this website or disclose personal information collected through this website if the user has consented to the collection or disclosure of such personal information. The voluntary disclosure of personal information to the New York State Department of Health AIDS Institute by the user, whether solicited or unsolicited, constitutes consent to the collection and disclosure of the information by the New York State Department of Health AIDS Institute for the purposes for which the user disclosed the information to the New York State Department of Health AIDS Institute, as was reasonably ascertainable from the nature and terms of the disclosure.

However, the New York State Department of Health AIDS Institute may collect or disclose personal information without consent if the collection or disclosure is: (1) necessary to perform the statutory duties of the New York State Department of Health AIDS Institute, or necessary for the New York State Department of Health AIDS Institute to operate a program authorized by law, or authorized by state or federal statute or regulation; (2) made pursuant to a court order or by law; (3) for the purpose of validating the identity of the user; or (4) of information to be used solely for statistical purposes that is in a form that cannot be used to identify any particular person.

Further, the disclosure of information, including personal information, collected through this website is subject to the provisions of the Freedom of Information Law and the Personal Privacy Protection Law.

The New York State Department of Health AIDS Institute may also disclose personal information to federal or state law enforcement authorities to enforce its rights against unauthorized access or attempted unauthorized access to the New York State Department of Health AIDS Institute’s information technology assets.

Retention of Information Collected Through This Website

The information collected through this website is retained by the New York State Department of Health AIDS Institute in accordance with the records retention and disposition requirements of the New York State Arts & Cultural Affairs Law. In general, the Internet services logs of the New York State Department of Health AIDS Institute, comprising electronic files or automated logs created to monitor access and use of Agency services provided through this website, are retained for 1 year and then destroyed, absent a specific need or obligation to retain it for a longer period. Information, including personal information, that you submit in an e-mail or when you complete a survey, registration form, or order form is retained in accordance with the records retention and disposition schedule established for the records of the program unit to which you submitted the information. Information concerning these records retention and disposition schedules may be obtained through the Internet privacy policy contact listed in this policy.

Access to and Correction of Personal Information Collected Through This Website

Except as otherwise provided by law, any user may submit a request to the New York State Department of Health AIDS Institute privacy compliance officer to determine whether personal information pertaining to that user has been collected through this website. Any such request shall be made in writing and must be accompanied by reasonable proof of identity of the user. Reasonable proof of identity may include verification of a signature, inclusion of an identifier generally known only to the user, or similar appropriate identification. The address of the privacy compliance officer is:

New York Department of Health
Corning Tower, Room 2348
Albany, New York 12237-0044

Except as otherwise provided by law, the privacy compliance officer shall, within five (5) business days of the receipt of a proper request, provide access to the personal information; deny access in writing, explaining the reasons thereof; or acknowledge the receipt of the request in writing, stating the approximate date when the request will be granted or denied, which date shall not be more than thirty (30) days from the date of the acknowledgment.

In the event that the New York State Department of Health AIDS Institute has collected personal information pertaining to a user through the state agency website and that information is to be provided to the user pursuant to the user’s request, the privacy compliance officer shall inform the user of his or her right to request that the personal information be amended or corrected under the procedures set forth in section 95 of the Public Officers Law, except as otherwise provided by law.

Confidentiality and Integrity of Personal Information Collected Through This Website

The New York State Department of Health AIDS Institute is strongly committed to protecting personal information collected through this website against unauthorized access, use or disclosure. Consequently, the New York State Department of Health AIDS Institute limits employee access to personal information collected through this website to only those employees who need access to the information in the performance of their official duties. Employees who have access to this information follow appropriate procedures in connection with any disclosures of personal information.

In addition, the New York State Department of Health AIDS Institute has implemented procedures to safeguard the integrity of its information technology assets, including, but not limited to, authentication, monitoring, auditing, and encryption. These security procedures have been integrated into the design, implementation, and day-to-day operations of this website as part of our continuing commitment to the security of electronic content as well as the electronic transmission of information.

For website security purposes and to maintain the availability of the website for all users, the Agency employs software to monitor traffic to identify unauthorized attempts to upload or change information or otherwise damage this website.

Disclaimer

The information provided in this privacy policy should not be construed as giving business, legal, or other advice, or warranting as fail proof, the security of information provided through this website.

Definitions

The following definitions apply to, and appear in italics, in this policy:

  • Personal Information shall have the meaning set forth in subdivision 5 of section 202 of the State Technology Law.
  • State Agency Website shall have the meaning set forth in subdivision 7 of section 202 of the State Technology Law.
  • User shall have the meaning set forth in subdivision 8 of section 202 of the State Technology Law.